K
Market Data
$19.20−$2.18 (−10.20%)
KROS · Last trade
Prev Close
$21.38
Range (30d)
$17.79 – $21.36
Recent Filings
- 8-K4.5 MBKeros Therapeutics, Inc.Jan 9, 4:16 PM ET·0001664710-26-000003
- 10-Q6.0 MBKeros Therapeutics, Inc.Nov 5, 4:05 PM ET·0001664710-25-000089
- 8-K287.5 KBKeros Therapeutics, Inc.Nov 5, 4:02 PM ET·0001664710-25-000086
- 8-K532.7 KBKeros Therapeutics, Inc.Oct 15, 6:40 AM ET·0001104659-25-099512
- 8-K221.0 KBKeros Therapeutics, Inc.Sep 8, 8:02 AM ET·0001664710-25-000081
- 8-K214.0 KBKeros Therapeutics, Inc.Aug 28, 4:02 PM ET·0001664710-25-000078
- 8-K215.9 KBKeros Therapeutics, Inc.Aug 20, 9:50 AM ET·0001664710-25-000073
- 8-K6.8 MBKeros Therapeutics, Inc.Aug 6, 4:18 PM ET·0001664710-25-000071
- 10-Q5.9 MBKeros Therapeutics, Inc.Aug 6, 4:06 PM ET·0001664710-25-000070
- 8-K287.3 KBKeros Therapeutics, Inc.Aug 6, 4:03 PM ET·0001664710-25-000068
Insiders
10- ADAR1 Capital Management, LLC10% Owner
- ADAR1 Partners, LP10% Owner
- Arkin Bio Ventures Limited Partnership10% Owner
- Arkin Moshe10% Owner
- BIENAIME JEAN JACQUESDirector
- Cho EstherSVP, General Counsel
- CHYUNG YUNG H.Chief Medical Officer
- Cooper Simon PeterChief Medical Officer
- Farzan NimaDirector
- GORDON CARL LDirector
Tickers
Addresses
business
1050 WALTHAM STREET, SUITE 302
LEXINGTON, MA, 02421
mailing
1050 WALTHAM STREET, SUITE 302
LEXINGTON, MA, 02421